Over the last 12 hours, the dominant health story in the coverage is the ongoing response to a suspected hantavirus outbreak aboard the MV Hondius off Cape Verde, with multiple updates focusing on evacuations, international coordination, and risk assessment. The WHO says three people (two sick crew members and one contact) were evacuated and were “stable,” with one asymptomatic, while the ship continued toward Spain’s Canary Islands. Spain’s health authorities also indicated the vessel would proceed to Tenerife for further medical examinations and repatriations, and reporting describes evacuees being flown onward to Europe (including Amsterdam). Several articles also stress that WHO leadership and experts are not framing the event as a “COVID-like” crisis, repeatedly describing the broader public risk as low and noting that transmission is uncommon and typically requires close contact.
South Africa’s role in the response is also a key thread in the most recent reporting. Reuters-style coverage says South Africa identified the Andes strain in two people linked to the outbreak—one Dutch woman who died in Johannesburg and a British man still hospitalised—described as the strain associated with rare human-to-human transmission. Other reporting highlights scrutiny of South Africa’s airport health-screening and contact/notification processes: MPs questioned whether airport officials were alerted in advance, and the health minister’s briefing (as reported) indicated there was no prior alert from the airline and that the passenger presented like any other traveller at OR Tambo. Additional coverage notes that US CDC monitoring of American passengers is underway, with the CDC stating the risk to the wider public is “very low.”
Alongside the outbreak, the last 12 hours include other health-related items that are more routine or informational rather than outbreak-driven. These include a piece debunking “common medical myths,” and skin-cancer prevention messaging tied to Skin Cancer Awareness Month (including advice about early protection and early detection). There is also a separate, major health-industry development: Aspen Pharmacare received approval to begin commercial release of its first locally manufactured human insulin batches, with the article framing it as a milestone for local pharmaceutical manufacturing and broader African markets.
In the 12–72 hours window, the coverage provides continuity on the outbreak’s escalation and the international “contact tracing + evacuation” approach. Multiple reports describe WHO warnings about possible human-to-human transmission (while still characterising public risk as low), the ship’s docking disputes and changing destination plans, and the growing number of confirmed/suspected cases. Background reporting also points to investigators in Argentina working to identify the outbreak’s likely origin, including hypotheses involving exposure during bird-watching/landfill visits, and notes that the Andes strain is implicated. However, compared with the outbreak’s dense, fast-moving updates in the last 12 hours, the older material here functions mainly as context for how the response evolved rather than introducing new South Africa-specific developments.